Abstract | OBJECTIVES: METHODS:
Monosodium iodoacetate (MIA) was used to establish OA chronic pain model. After 21 days, the rats received tDCS for 14 consecutive days (20 min/day). We assessed the pain-related behaviors of rats at different time points. Western blot and Immunohistochemistry were performed to observe the expression level of NMDAR2B in the spinal cord after tDCS treatment. RESULTS: After MIA injection, rats developed apparent mechanical hyperalgesia and thermal hyperalgesia. However, the pain-related behaviors of rats were significantly improved after tDCS treatment. In addition, the expression of NMDAR2B and the proportion of positive stained cells of NMDAR2B were reversed by tDCS treatment. CONCLUSIONS: The results demonstrated that tDCS can attenuate OA-induced chronic pain in rats via reducing NMDAR2B expressions in the spinal cord. We believe that this may be the result of tDCS participating in the top-down modulation of pain pathway in the endogenous analgesic system.
|
Authors | Zhihua Liu, Xia Chen, Peng Chen, Lili Wang |
Journal | Journal of musculoskeletal & neuronal interactions
(J Musculoskelet Neuronal Interact)
Vol. 23
Issue 4
Pg. 498-505
(Dec 01 2023)
ISSN: 1108-7161 [Print] Greece |
PMID | 38037367
(Publication Type: Journal Article)
|
Chemical References |
- Analgesics
- Iodoacetic Acid
|
Topics |
- Rats
- Animals
- Chronic Pain
(therapy)
- Transcranial Direct Current Stimulation
(methods)
- Hyperalgesia
(metabolism, therapy)
- Osteoarthritis
(therapy, metabolism)
- Analgesics
- Iodoacetic Acid
(toxicity, metabolism)
- Spinal Cord
(metabolism)
|